160 HEALTH (02656) Company Profile - Company Info, Industry & Management

返回 Overview News Financials Shareholders Profile IPO ›

Industry

Pharmaceutical Distribution 0.24%

20 stocks in this industry

0 >7%

2 5~7%

1 3~5%

2 0~3%

4 0%

11 0~3%

0 3~5%

0 5~7%

0 >7%

Down 5 Up 11

Industry RankingsValue (HKD)Rank

Revenue (Last FY)764.42M14/19

Net Profit (Last FY)-85.59M19/19

ROE (Last FY)-30.53%19/19

Change is the 2026-10-09 close against the previous close; the industry change is the equal-weighted average of its stocks. Sub-industry classification is maintained by cibo. Last FY is each company's latest annual report. Net profit is profit attributable to owners of the parent; ROE = net profit / closing equity attributable to owners. Non-HKD statements are converted at ECB reference rates.

Management

NamePosition

Luo Ningzheng Executive Director

Ji Cuilin Executive Director

Huang Lang Executive Director

Wang Lifa Executive Director

Liu Haibin Non-Executive Director

Wang Huan Independent Non-Executive Director

Xu Weiguo Independent Non-Executive Director

Fan Ming Independent Non-Executive Director

Board list from the HKEXnews "List of Directors and their Role and Function", as of 2026-08-14.

About this page

This page shows 160 HEALTH (02656) company information, related securities, the price change distribution and in-industry rankings within its sub-industry, and the board of directors. Quotes come from HKEX Daily Quotations, financial metrics from each company's latest annual report, and the director list from HKEXnews.

160 HEALTH 02656

Company Information

Industry

Management

160 HEALTH 02656·

Company Information

Industry

Management

160 HEALTH 02656